Dimopoulos M, Tedeschi A, Trotman J, et al. Multinational, randomized phase 3 trial of ibrutinib-rituximab vs placebo-rituximab with Waldenström’s macroglobulinemia. EHA 2018, abstract S852.
Brentuximab vedotine plus chemotherapie voor CD30-positief perifeer T-cellymfoom
mrt 2019 | Lymfoom